SafeGuard Surgical
PrivateLast Round
Series A
Mar 14, 2024
Total Funding Raised
$1.11M
Company Overview
SafeGuard Surgical is a medical technology company that develops biodegradable surgical solutions, including the FDA-designated breakthrough device LeakGuard, to prevent surgical leaks and improve patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SafeGuard Surgical Comparables
Compare SafeGuard Surgical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Averto Medical | 89% | |
| SafeHeal | 86% | |
| Galmed Pharmaceuticals Ltd. | 86% | |
SafeGuard Surgical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 14, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2025
Grew 200% QoQ, from 2 to 6 employees.
- Mar 14, 2024
$1.1M round with Jameis Winston and Tom Pepin
SafeGuard Surgical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SafeGuard Surgical's valuation, stock price, and market status.